-
Mashup Score: 5Tirofiban Reduces Early Neurologic Deterioration After Stroke - 3 month(s) ago
Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.
Source: www.medscape.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 16Tirofiban Reduces Early Deterioration After Stroke - 3 month(s) ago
Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15Mixed Results for Low-Dose Steroids With Thrombectomy - 3 month(s) ago
Adding low-dose methylprednisolone to stroke thrombectomy did not improve overall disability, but there were other possible benefits seen in the MARVEL trial.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Lying Flat Shows Big Benefit in LVO Stroke - 3 month(s) ago
Patients with large vessel occlusion strokes showed an impressive benefit from having their head lowered to a flat position until thrombectomy, in the ZODIAC trial.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Head Position Before Surgery May Improve Neurological Function in Stroke Patients | Docwire News - 3 month(s) ago
Patients whose heads are positioned at a 0-degree angle prior to surgery have significantly improved neurological function compared with those patients whose heads are elevated.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 17Program Planner - 5 month(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: General Medicine News, NeurologyTweet
IV administration of the antiplatelet agent tirofiban for 72 hours was associated with a reduction in early neurologic deterioration compared with oral aspirin therapy in patients with acute ischemic #stroke, in the randomized TREND trial. #ISC24 https://t.co/rGetP4Cjp3 https://t.co/f6tIU8SBkw